1-20 of 241
Depei Wu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax and Decitabine vs Intensive Chemotherapy as Induction for Young Patients with Newly Diagnosed AML

Jing Lu, Shengli Xue, Ying Wang, Xuefeng He, Xiaohui Hu, Miao Miao, Yang Zhang, Zaixiang Tang, Jundan Xie, Xiaofei Yang, Mingzhu Xu, Yaoyao Shen, Feng Du, Qian Wu, Mengxing Xue, Yun Wang, Ailing Deng, Xueqing Dou, Yang Xu, Haiping Dai, Depei Wu, Suning Chen
Journal: Blood
Blood blood.2024027217.
https://doi.org/10.1182/blood.2024027217
Published: 2025
Includes: Supplemental data
Journal Articles

YAP1 regulates thrombopoiesis by binding to MYH9 in immune thrombocytopenia

Shuhong Hu, Yifei Liu, Xiang Zhang, Xiaoqi Wang, Yanting Li, Mengqian Chu, Jie Yin, Yanglan Fang, Changgeng Ruan, Li Zhu, Depei Wu, Yang Xu
Journal: Blood
Blood (2024) 144 (20): 2136–2148.
https://doi.org/10.1182/blood.2023023601
Published: 2024
Includes: Supplemental data
Journal Articles

Venetoclax and Decitabine Compared with Standard Intensive Chemotherapy As Induction Therapy in Newly Diagnosed Acute Myeloid Leukemia: Updated Results of a Multicenter, Randomized, Phase 2b Trial

Jing Lu, Shengli Xue, Ying Wang, Xuefeng He, Xiaohui Hu, Miao Miao, Yang Zhang, Zaixiang Tang, Jundan Xie, Xiaofei Yang, Mingzhu Xu, Yaoyao Shen, Feng Du, Qian Vicky Wu, Mengxing Xue, Yun Wang, Ailing Deng, Xueqing Dou, Haiping Dai, Depei Wu, Suning Chen
Journal: Blood
Blood (2024) 144 (Supplement 1): 971.
https://doi.org/10.1182/blood-2024-202801
Published: 2024
Journal Articles

Clinical Characteristics and Treament Outcomes of 104 Cases of Extranodal NK/T-Cell Lymphoma Undergoing Primary Treatment in Novel Agents Era

Haiwen Huang, Mao Jin, Caixia Li, Zhengming Jin, Depei Wu
Journal: Blood
Blood (2024) 144 (Supplement 1): 1676.
https://doi.org/10.1182/blood-2024-201884
Published: 2024
Journal Articles

Better Outcome Following Younger Haploidentical Donor Versus Older Matched Unrelated Donor Transplant for Patients with Acute Myeloid Leukemia in First Remission: A Study from the Global Committee and Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Yishan Ye, Allain Thibeault Ferhat Berland, Myriam Labopin, Jia Chen, Depei Wu, Didier Blaise, Emanuele Angelucci, Edouard Forcade, Xiao-Jun Huang, Ibrahim Yakoub-Agha, Urpu Salmenniemi, Patrice Chevallier, Ali Bazarbachi, Arnon Nagler, Eolia Brissot, Lin Li, Yi Luo, Yanmin Zhao, Fabio Ciceri, He Huang, Mohamad Mohty, Norbert Claude Gorin, Sr.
Journal: Blood
Blood (2024) 144 (Supplement 1): 2180.
https://doi.org/10.1182/blood-2024-200423
Published: 2024
Journal Articles

Autologous Hematopoietic Stem Cell Transplantation in Natural Killer/T-Cell Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party

Philipp Berning, Maud Ngoya, Hervé Finel, Nassila Thani, Evgenii Shumilov, Depei Wu, Haiwen Huang, Won Seog Kim, Anne Cairoli, Alessandra Tucci, Guillaume Dachy, Romain Gounot, Anne Wilke, Marek Werth, Christof Scheid, Peter Dreger, Jose Luis Lopez Lorenzo, Adrian Bloor, Joanna Romejko-Jarosinska, Alain Gadisseur, Roland Schroers, Péter Pál Reményi, Anne Sirvent, Monica Poiani, Khalid Halahleh, Jacques-Emmanuel Galimard, Georg Lenz, Bertram Glass, Ana Maria Sureda Balari, Ali Bazarbachi, Norbert Schmitz
Journal: Blood
Blood (2024) 144 (Supplement 1): 3070.
https://doi.org/10.1182/blood-2024-207545
Published: 2024
Journal Articles

Safety and Efficacy of VA Combined with Modified BuCy Conditioning Regimen Followed By Allo-HSCT for High-Risk or Refractory/Relapsed Acute Lymphoblastic Leukemia : A Prospective, Single-Center, Single-Arm Clinical Trial

Xiaoqian Chen, Wei Cui, Qingya Cui, Zheng Li, Sifan Chen, Mengyun Li, Xuekai Li, Juan Chen, Yan Yu, Xin Zhang, Depei Wu, Xiaowen Tang
Journal: Blood
Blood (2024) 144 (Supplement 1): 270.
https://doi.org/10.1182/blood-2024-209163
Published: 2024
Journal Articles

Sequential Infusion of Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor T-Cells: A Promising Treatment Strategy for Refractory Immune-Mediated Platelet Transfusion Refractoriness

Yunju Ma, Qingya Cui, Chunxiu Yang, Wei Cui, Mengyun Li, Zheng Li, Haiping Dai, Liqing Kang, Lei Yu, Zaixiang Tang, Jianxin Fu, Min Jiang, Depei Wu, Xiaowen Tang
Journal: Blood
Blood (2024) 144 (Supplement 1): 683.
https://doi.org/10.1182/blood-2024-209249
Published: 2024
Journal Articles

A Phase II Study to Evaluate the Efficacy and Safety of Pimicotinib (ABSK021) in Chronic Graft Versus Host Disease (cGvHD) after 1 or More Lines of Systemic Treatment

Xiaodong Mo, He Huang, Feng Chen, Yi Luo, Jia Chen, Erlie Jiang, Yicheng Zhang, Linghui Xia, Chengwei Luo Luo, Xinchuan Chen, Nainong Li, Ming Jiang, Sujun Gao, Dongqin Yang, Qingli Zuo, Yimin Chen, Li Yao, Pan Liang, Depei Wu
Journal: Blood
Blood (2024) 144 (Supplement 1): 99.
https://doi.org/10.1182/blood-2024-193191
Published: 2024
Journal Articles

Hematopoietic Stem Cell Transplantation in Hepatosplenic T-Cell Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party

Imke E. Karsten, Norbert Schmitz, Mathilde Fekom, Laurence de Leval, Hervé Finel, Irma Khvedelidze, Won Seog Kim, Depei Wu, Montserrat Rovira, Fengrong WANG, Xiao-Jun Huang, Peter Dreger, Johan Maertens, Paolo Corradini, Grzegorz Helbig, Wolfgang Andreas Bethge, Larry Bacon, Jan Vydra, Aitana Balaguer Rosello, Matthias Stelljes, Georg Lenz, Alina Daniela Tanase, Anna Sureda Balari, Ali Bazarbachi, Bertram Glass
Journal: Blood
Blood (2024) 144 (Supplement 1): 399.
https://doi.org/10.1182/blood-2024-210100
Published: 2024
Journal Articles

Prospective Study of Avapritinib in Patients with Relapsed/Refractory or MRD-Positive Core-Binding Factor Acute Myeloid Leukemia with KIT Mutations

Xueqing Dou, Suning Chen, Depei Wu
Journal: Blood
Blood (2024) 144 (Supplement 1): 222.
https://doi.org/10.1182/blood-2024-207264
Published: 2024
Journal Articles

Large-Scale Metabolomic Mendelian Randomization Analysis Identifies Pyridoxate As a Key Factor in Graft-Versus-Host Disease

Xinghao Yu, Yiyin Chen, Lei Lei, Dandan Lin, Ying Shen, Chang Hou, Jia Chen, Yi Fan, Huimin Lu, Depei Wu, Yang Xu
Journal: Blood
Blood (2024) 144 (Supplement 1): 3523.
https://doi.org/10.1182/blood-2024-206745
Published: 2024
Journal Articles

Short-Term Blinatumomab Prior to Allo-HSCT for High-Risk B-ALL

Huizhu Kang, Yuejun Liu, Ruju Wang, Meng Zhou, Chengyuan Gu, Xuefeng He, Jun Chen, Zhihong Lin, Depei Wu, Yue Han
Journal: Blood
Blood (2024) 144 (Supplement 1): 3494.
https://doi.org/10.1182/blood-2024-208142
Published: 2024
Journal Articles

Obinutuzumab Is a Promising Alternative for the Treatment of Relapsed or Refractory Autoimmune Hematological Disorders

Haiju He, Hong Tian, Yun Li, Ziqiang Yu, Depei Wu, Jie Yin
Journal: Blood
Blood (2024) 144 (Supplement 1): 3940.
https://doi.org/10.1182/blood-2024-210054
Published: 2024
Journal Articles

Glofitamab Combined with Salvage Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Real-World Prospective Observational Study in Chinese Patients

Jingxian Gu, Tao You, Peng Xu, Jiebing Xiao, Wei Dai, Zhengming Jin, Xiao Ma, Depei Wu, Haiwen Huang
Journal: Blood
Blood (2024) 144 (Supplement 1): 6530.
https://doi.org/10.1182/blood-2024-203283
Published: 2024
Journal Articles

In AML Patients Allografted in First Remission, DNMT3A Mutations Differentially Affect Post-Transplant Outcomes According to Karyotype, NPM1 and FLT3-ITD Mutation Status - from the EBMT-ALWP

Iman Abou Dalle, Jacques-Emmanuel Galimard, Xavier Poiré, Jaime Sanz, Anne Huynh, Nicolaus Kröger, Eva-Maria Wagner Drouet, David Burns, Matthias Eder, Bruno Lioure, Depei Wu, Jiri Mayer, Kristina Carlson, Matthias Stelljes, Matthew Collin, Mahmoud Aljurf, Arnon Nagler, Jordi Esteve, Fabio Ciceri, Ali Bazarbachi, Mohamad Mohty
Journal: Blood
Blood (2024) 144 (Supplement 1): 4315.
https://doi.org/10.1182/blood-2024-202764
Published: 2024
Journal Articles

5-Year Follow-up of Combined Infusion of Anti-CD19 and Anti-BCMA CAR-T after ASCT for High-Risk Newly Diagnosed Multiple Myeloma

Xiaolan Shi, Chengcheng Fu, Lingzhi Yan, Yingying Zhai, Zhi Yan, Jingjing Shang, Song Jin, Xingyue Wu, Hongying You, Shuang Yan, Weiqin Yao, Liqing Kang, Lei Yu, Depei Wu
Journal: Blood
Blood (2024) 144 (Supplement 1): 4766.
https://doi.org/10.1182/blood-2024-207687
Published: 2024
Journal Articles

Comparing the Efficacy and Safety of VAC (Venetoclax, Azacitidine, Chidamide) and VA Regimens As Induction Therapy for Newly Diagnosed Patients with Immunophenotypically Mature Monocytic AML

Kai-Wen Tan, Shanshan Pei, Miao Wang, Lan Dai, Hao Zhang, Chun-Yan Chen, Zhen-Qi Huang, Hai-Ping Dai, Ying Wang, Miao Miao, Yue Han, Xiaowen Tang, Huiying Qiu, Suning Chen, Aining Sun, Depei Wu, Zheng Li, Sheng-Li Xue
Journal: Blood
Blood (2024) 144 (Supplement 1): 1507.
https://doi.org/10.1182/blood-2024-204762
Published: 2024
Journal Articles

Bird Regimen Followed By Anti-BCMA CAR T-Cell Immunotherapy As First-Line Therapy for Newly Diagnosed Multiple Myeloma: A Prospective, Single-Arm, Phase 3 Trial

Yue Zhou, Juan Chen, Qingya Cui, Haiping Dai, Zheng Li, Jia Yin, Wei Cui, Mengyun Li, Xuekai Li, Xin Zhang, Feiran Gong, Xiaming Zhu, Liqing Kang, Lei Yu, Depei Wu, Xiaowen Tang
Journal: Blood
Blood (2024) 144 (Supplement 1): 3384.
https://doi.org/10.1182/blood-2024-199119
Published: 2024
Journal Articles

Interim Analysis of Dara VRD in the Treatment of TE-NDMM Patients with Standard Risk Who Refused to Accept ASCT As First Line in China

Chengcheng Fu, Jing Wang, Song Jin, Lingzhi Yan, Jingjing Shang, Weiqin Yao, Xiaolan Shi, Zhi Yan, Depei Wu
Journal: Blood
Blood (2024) 144 (Supplement 1): 1997.
https://doi.org/10.1182/blood-2024-209260
Published: 2024